Cargando…

Neutralization of Interferon-gamma is efficacious in a mouse model of HLH secondary to chronic inflammation

Detalles Bibliográficos
Autores principales:	Prencipe, G, Caiello, I, Bracaglia, C, de Min, C, De Benedetti, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596982/ http://dx.doi.org/10.1186/1546-0096-13-S1-O29

Ejemplares similares

Interferon-gamma (IFNy) in macrophage activation syndrome (MAS) associated with systemic juvenile idiopathic arthritis (sJIA). High levels in patients and a role in a murine mas model
por: Bracaglia, Claudia, et al.
Publicado: (2014)

High levels of interferon-gamma (IFNγ) in macrophage activation syndrome (MAS) and CXCL9 levels as a biomarker for IFNγ production in MAS
por: Bracaglia, C, et al.
Publicado: (2015)

Interferon gamma (IFNg) production is associated to disease parameters in TLR9-induced secondary hemophagocytic lymphohistiocytosis (sHLH) in mice
por: De Min, Cristina, et al.
Publicado: (2014)

PReS-FINAL-2186: Monoallelic mutations of familial hlh-related genes associated to macrophage activation syndrome
por: Bracaglia, C, et al.
Publicado: (2013)

Monocytes From Patients With Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis Are Hyperresponsive to Interferon Gamma
por: Pascarella, Antonia, et al.
Publicado: (2021)

Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis
por: Bracaglia, C, et al.
Publicado: (2015)

S100A12 as diagnostic tool in the differential diagnosis of sJIA associated MAS vs. hereditary or acquired HLH
por: Holzinger, D, et al.
Publicado: (2015)

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis
por: Prencipe, Giusi, et al.
Publicado: (2019)

Involvement of the IFN-gamma pathway in a patient with candle syndrome carrying a novel variant of PSMB8 gene
por: Insalaco, Antonella, et al.
Publicado: (2014)

Inhibition of natural killer (nk) cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome
por: Cifaldi, Loredana, et al.
Publicado: (2014)

Inflammatory Cytokine response in a cohort of patients carrying novel NLRP12 variants
por: Raganelli, L, et al.
Publicado: (2015)

Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism
por: Minnone, G, et al.
Publicado: (2011)

Interferon gamma (IFNg) drives disease in the TLR9-mediated cytokine storm syndrome in mice
por: de Min, C, et al.
Publicado: (2015)

PReS-FINAL-2183: IL-6 amplifies toll like receptor mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases
por: Caiello, I, et al.
Publicado: (2013)

Severe peripheral blood lymphopenia without NK cell cytotoxicty deficiency is the rule in adult acquired HLH
por: Carvelli, J, et al.
Publicado: (2015)

Cell biology of synovial inflammation and secondary osteoporosis in rheumatoid arthritis
por: Tanaka, Y, et al.
Publicado: (2003)

Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2014)

PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS
por: Insalaco, A, et al.
Publicado: (2013)

Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism
por: Minnone, G, et al.
Publicado: (2011)

Tracing cellular sources of pathogenic type I-interferon in the TREX1(-/-) mouse model of lupus like-disease
por: Peschke, K, et al.
Publicado: (2015)

Immune-based therapy using gamma interferon ingaron in the treatment of HIV/AIDS patients with active pulmonary tuberculosis (PTB) not previously highly active antiretroviral therapy (HAART)
por: Yola, Auwal, et al.
Publicado: (2006)

Therapeutic neutralization of interferon-gamma in primates prevents lethality in Gram-negative bacteremic shock
por: Lainée, P, et al.
Publicado: (2004)

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Arduini, Alessia, et al.
Publicado: (2019)

Haematological and molecular responses in patients with chronic ATLL treated with zidovudine and interferon-α
por: Hodson, Andrew, et al.
Publicado: (2014)

Mouse APOBEC3 affects the production of virus-neutralizing antibodies by restricting early retroviral replication, not by altering the B-cell repertoire
por: Miyazawa, Masaaki, et al.
Publicado: (2009)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

O017. Cortical functional correlates of responsiveness to short-lasting preventive intervention with ketogenic diet (KD) in migraine: a multimodal evoked potentials study
por: Bracaglia, Martina, et al.
Publicado: (2015)

Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome
por: Bracaglia, Claudia, et al.
Publicado: (2017)

Contrast-dependent modulation of gamma rhythm in v1: a network model
por: Zachariou, Margarita, et al.
Publicado: (2015)

Efficacy of multidisciplinary rehabilitation of patients with chronic headache
por: Gaul, C
Publicado: (2013)

Endogenous and exogenous regulation of gamma-secretase
por: Li, Yueming
Publicado: (2013)

Non-neutralizing antibodies and vaccine-induced protection
por: Demberg, Thorsten, et al.
Publicado: (2006)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

HIV infection destabilizes a targeted subset of the gamma/delta T cell repertoire
por: Hebbeler, Andrew M, et al.
Publicado: (2006)

O025. Excitability of the motor cortex in migraine changes with the distance from the last attack
por: Coppola, Gianluca, et al.
Publicado: (2015)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Design clues from functional constraints and broadly neutralizing antibodies
por: Zhou, Tongqing, et al.
Publicado: (2006)

Epigenetics & modern phenotypes: the biological nonsense of sub-talar neutral
por: Quinn, Greg
Publicado: (2010)

Neutral contrast MRI for the detection of peripheral arterial wall calcifications
por: Edelman, Robert R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_orbl9d6mg26ennh6vq0e27sbe2